Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07175935

Amyotrophic Lateral Sclerosis Registry in Thailand

A Prospective, Multicenter Registry Study of Amyotrophic Lateral Sclerosis in Thailand

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral sclerosis (ALS) across Thailand. The registry will establish a national dataset to describe epidemiology, clinical presentation, progression, and treatment outcomes, and will serve as a platform for future clinical and translational research.

Detailed description

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder that affects upper and lower motor neurons, leading to progressive muscle weakness, disability, and respiratory failure. Despite increasing research worldwide, Thailand lacks large-scale systematic data on ALS epidemiology, clinical characteristics, genetic profiles, and outcomes. This registry will prospectively enroll ALS patients from major academic hospitals and specialized neuromuscular centers nationwide. Patients will be followed longitudinally using standardized assessments, including ALSFRS-R, staging systems (King, MiTos, 9-point), motor and respiratory function, quality-of-life measures, and cognitive/behavioral evaluations. Data will be collected through a REDCap electronic database, ensuring confidentiality and compliance with Thai PDPA and international data protection standards. No experimental interventions will be performed; patients will receive standard of care treatments as determined by their treating physicians.

Conditions

Timeline

Start date
2025-03-01
Primary completion
2030-12-31
Completion
2030-12-31
First posted
2025-09-16
Last updated
2025-09-16

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT07175935. Inclusion in this directory is not an endorsement.